MENU
+Compare
RPRX
Stock ticker: NASDAQ
AS OF
Aug 13, 10:49 AM (EDT)
Price
$36.05
Change
+$0.20 (+0.56%)
Capitalization
15.5B

RPRX Royalty Pharma plc Forecast, Technical & Fundamental Analysis

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties... Show more

RPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RPRX with price predictions
Aug 12, 2025

RPRX in upward trend: price may ascend as a result of having broken its lower Bollinger Band on August 12, 2025

RPRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 42 cases where RPRX's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RPRX advanced for three days, in of 288 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 203 cases where RPRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for RPRX moved out of overbought territory on August 06, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on August 11, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RPRX as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for RPRX turned negative on August 11, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RPRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.464) is normal, around the industry mean (18.823). P/E Ratio (15.808) is within average values for comparable stocks, (53.986). Projected Growth (PEG Ratio) (3.148) is also within normal values, averaging (2.906). Dividend Yield (0.024) settles around the average of (0.049) among similar stocks. P/S Ratio (9.116) is also within normal values, averaging (290.538).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RPRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RPRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
RPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RPRX is expected to report earnings to fall 12.44% to 99 cents per share on November 05

Royalty Pharma plc RPRX Stock Earnings Reports
Q3'25
Est.
$1.00
Q2'25
Beat
by $0.10
Q1'25
Missed
by $0.66
Q4'24
Missed
by $0.63
Q3'24
Missed
by $0.01
The last earnings report on August 06 showed earnings per share of $1.14, beating the estimate of $1.04. With 63.68K shares outstanding, the current market capitalization sits at 15.50B.
A.I.Advisor
published Dividends

RPRX is expected to pay dividends on September 10, 2025

Royalty Pharma plc RPRX Stock Dividends
A dividend of $0.22 per share will be paid with a record date of September 10, 2025, and an ex-dividend date of August 15, 2025. The last dividend of $0.22 was paid on June 10. Read more...
A.I. Advisor
published General Information

General Information

a provider of drug development services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
110 East 59th Street
Phone
+1 212 883-0200
Employees
89
Web
https://www.royaltypharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
HZEN0.860.03
+3.61%
Grayscale Horizen Trust (ZEN)
FTXL101.383.24
+3.30%
First Trust Nasdaq Semiconductor ETF
ARTY43.040.65
+1.53%
iShares Future AI & Tech ETF
SPWO24.740.28
+1.14%
SP Funds S&P World ETF
FSIG19.170.01
+0.05%
First Trust Ltd Drtn Inv Grd Corp ETF

RPRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RPRX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RPRX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPRX
1D Price
Change %
RPRX100%
-0.91%
AXON - RPRX
48%
Loosely correlated
-6.12%
MDGL - RPRX
31%
Poorly correlated
+2.72%
ARRY - RPRX
30%
Poorly correlated
+2.55%
DTIL - RPRX
29%
Poorly correlated
+0.69%
QURE - RPRX
29%
Poorly correlated
+1.27%
More